Bortezomib will increase the stage or effect of flibanserin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe. Enhanced flibanserin adverse consequences may possibly occur if coadministered with several weak CYP3A4 inhibitors. Significant: The drug info on this web page is meant to become academic. It is not a substitute for https://denisv000juf3.bloggadores.com/26529102/5-easy-facts-about-dup-747-described